Central post-stroke pain (CPSP) rarely goes away on its own. It is a chronic neuropathic pain condition caused by lasting damage to the brain’s pain-processing pathways, and for most people who develop it, the pain persists long-term. That said, the severity can often be reduced significantly with the right combination of treatments, and some people do experience meaningful improvement over time.
Why CPSP Tends to Persist
CPSP isn’t caused by ongoing tissue damage in the body. It originates in the brain itself. A stroke that disrupts the pathways carrying sensory information, particularly the tract connecting the spinal cord to the thalamus, can leave parts of the brain in a permanently hyperexcitable state. The thalamus, the insula, and areas involved in emotional processing of pain essentially lose their normal “braking” systems. Inhibitory signals that would normally keep pain circuits quiet are weakened, so the brain generates pain signals even without any painful stimulus reaching it from the body.
This loss of inhibition also extends to the motor cortex, the part of the brain that controls movement. Research using brain stimulation techniques has shown that CPSP patients have measurably reduced inhibition in the motor cortex, and this reduction correlates with worse quality of life. Because the underlying problem is structural brain damage rather than inflammation or a healing injury, the pain doesn’t follow the typical trajectory of an injury that improves as the body repairs itself.
Who Develops It and When
About 11% of all stroke survivors develop CPSP. That number climbs sharply for certain stroke locations: more than 50% of people with strokes affecting the thalamus or the brainstem (specifically the medulla) go on to develop it. The pain most commonly appears between one and six months after the stroke, though the timeline varies widely.
In a large meta-analysis, 26% of CPSP cases began at the same time as the stroke itself, 31% appeared within the first month, and 41% developed between one month and one year later. A small group, about 5%, didn’t develop symptoms until more than a year after their stroke. This delayed onset is one reason the condition is frequently missed or misdiagnosed.
The pain typically involves burning, aching, or pressure-like sensations on the side of the body affected by the stroke. Many people also experience heightened sensitivity to touch or temperature, where stimuli that wouldn’t normally be painful become intensely uncomfortable.
How It Affects Daily Life
CPSP takes a toll beyond the physical sensation of pain. People with the condition report significantly lower scores in thinking and energy compared to stroke survivors without it. Depression is common and compounds the problem: stroke patients who have both CPSP and depression report substantially worse overall quality of life than those dealing with either condition alone. Burning or pressure-type pain, in particular, is associated with greater reductions in daily functioning. The combination of chronic pain, fatigue, and cognitive difficulty can make rehabilitation from the stroke itself more difficult.
Medications That Help
No single medication eliminates CPSP entirely, but several can meaningfully reduce pain intensity. Pharmacological treatments achieve an average pain reduction of about 58%, which for many people represents the difference between debilitating pain and manageable discomfort.
The most commonly recommended first-line options include certain antidepressants (tricyclics like amitriptyline and newer types like duloxetine) and anticonvulsants (pregabalin and lamotrigine). These medications work not by treating depression or seizures but by calming overactive nerve signaling in the brain. Amitriptyline and duloxetine have the most robust evidence supporting their use for CPSP specifically.
A network meta-analysis comparing multiple treatments found that some less commonly used options actually ranked highest for pain reduction. Anti-seizure medications and certain anti-inflammatory approaches showed large effect sizes compared to placebo. Pregabalin, one of the most frequently prescribed options, showed a statistically significant but more modest benefit. Finding the right medication often requires trying more than one, and many patients end up on a combination.
Brain Stimulation and Other Approaches
Repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique that uses magnetic pulses to stimulate specific brain areas, has emerged as the neuromodulation treatment with the strongest evidence for CPSP. When targeted at the motor cortex, rTMS appears to help restore some of the lost inhibition driving the pain. Neuromodulation treatments as a group produce a moderate effect on pain scores, with an average reduction of about 31%.
Acupuncture and virtual reality therapies have shown some early promise, though the evidence base is still limited. Physical therapy approaches haven’t yet demonstrated a statistically significant effect on CPSP pain in pooled analyses, but they remain important for overall stroke recovery and mobility.
What Improvement Looks Like
For most people with CPSP, “getting better” means achieving effective pain management rather than complete resolution. The goal shifts from eliminating pain to reducing it enough to sleep, participate in rehabilitation, and maintain daily activities. Some people find that their pain intensity decreases gradually over months or years, particularly with consistent treatment. Others maintain a stable level of pain that responds to medication.
Early identification matters. Because CPSP can appear anywhere from the day of the stroke to over a year later, any new burning, tingling, or unusual pain on the stroke-affected side should be evaluated promptly. Starting treatment earlier gives a better chance of establishing effective pain control before the condition becomes deeply entrenched in the brain’s signaling patterns. The combination of the right medication with neuromodulation techniques like rTMS currently offers the most comprehensive approach to long-term management.